Page 3 - Demo

Welcome from Richard Paulson, CEO of Ipsen North America
Dear Colleague,
I’d like to wish you a warm welcome to Ipsen – we’re very happy to have you.
Here at Ipsen, the people and team are of primary importance. We have built our foundation through investing in— and building—trust and pushing our people to reach their full potential. Every day, our more than 5,400 employees worldwide, approximately 600 of whom, like you, are in North America, work diligently with the singular purpose of developing innovative medicines to improve the lives of patients around the world with difficult-to-treat diseases.
While a lot of companies may pride themselves on being patient-centric, we’re achieving that statement in a meaningful and bold way: by promising to deliver one new molecular entity or indication each year. The patients we serve across oncology, neuroscience and rare diseases don’t have time to wait, so we work with a sense of urgency and the agility of a biotech—leveraging our global reach—to bring innovative products to market sooner and into the hands of patients who need them most. We look forward to your work contributing to the achievement of that goal.
We are entering into a new era of innovation and growth as a leading global biotech company; by joining Ipsen during this time of unprecedented growth, you have the opportunity to work with our passionate and highly collaborative team as ONE Ipsen to achieve the best solutions for patients, healthcare providers, employees and the communities we serve.
We’re happy to have you onboard and are looking forward to continued success with you on our team.
Best,
Richard Paulson